More forecasts: Atlanta 30 day forecast
Lilly Shells Out $6.3 Billion For Boston Sleep-Drug Player Centessa
Mar 31, 2026
Eli Lilly will buy Boston‑based Centessa for about $6.3B, adding an orexin agonist program led by cleminorexton. The deal pays $38 per ADS up front and could reach $47 with milestones.












